Kingsway Financial Services signed a definitive agreement to purchase 95% of the shares of National Institute of Clinical Research, a provider of clinical trial site management and recruitment services for nephrology, cardiometabolic, infectious diseases and gastroenterology.
NICR participates in the development of innovative and life-saving therapies through its dedication to and focus on clinical research. NICR combines the use of the latest technologies, streamlined clinical operations, and extensive access to a diverse population to deliver the highest quality clinical trials for life-changing therapies. Read more.
